These included pathways mediating tumor cell proliferation, survival, and invasion (Fig. 2, E and F) as well as several essential molecular pathways that are known to be critical for the pathophysiology of ER+ breast cancers, in particular, the ESR1 and ERBB2 pathways (Fig. 2, G and H). This evidence concerns the gene ERBB2 and breast cancer.